# Insulin Degludec (Genetical Recombination) / Liraglutide (Genetical Recombination) Injection (ゾルトファイ配合注 フレックスタッチ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3969500G1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3969500G1029
- **Product name (Japanese):** ゾルトファイ配合注 フレックスタッチ
- **English title:** Insulin Degludec (Genetical Recombination) / Liraglutide (Genetical Recombination) Injection
- **Active ingredient:** インスリン デグルデク（遺伝子組換え）・リラグルチド（遺伝子組換え）
- **Active ingredient (INN):** Insulin Degludec (Genetical Recombination) / Liraglutide (Genetical Recombination)
- **Strength / unit:** １キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 396 Antidiabetics (糖尿病用剤)
- **Manufacturer:** Novo Nordisk Pharma (ノボ ノルディスク ファーマ)
- **NHI price (reference only):** JPY 3404 per １キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3969500G1029
- **JSON:** https://www.nifujipharma.com/api/drugs/3969500G1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Insulin%20Degludec%20(Genetical%20Recombination)%20%2F%20Liraglutide%20(Genetical%20Recombination)%20Injection%20(%E3%82%BE%E3%83%AB%E3%83%88%E3%83%95%E3%82%A1%E3%82%A4%E9%85%8D%E5%90%88%E6%B3%A8%20%E3%83%95%E3%83%AC%E3%83%83%E3%82%AF%E3%82%B9%E3%82%BF%E3%83%83%E3%83%81)%20%2F%20YJ%203969500G1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.